Angelika Vlachou

Angelika Vlachou is a Partner at High-Tech Gründerfonds (HTGF), one of Europe's most active seed investors, a role Angelika assumed on October 1, 2022.

Angelika is jointly responsible for HTGF's activities within the life science and chemistry sectors and serves on the board of various portfolio companies. Angelika Vlachou has over a decade of experience investing venture capital in biotech, pharma, and life science start-ups, managing transactions from seed-stage financing to IPOs.

Angelika's expertise is underpinned by a doctorate in biology and extensive virology-molecular biology research experience, allowing Angelika to effectively combine scientific innovation with commercial potential. Angelika began her professional career in investment banking before transitioning to venture capital, including a tenure at Brandenburg Kapital prior to joining HTGF's Life Sciences team in 2021.

Currently, Angelika is focused on further expanding HTGF's life sciences activities from the Berlin office.

Bio is AI generated & may not be accurate.